Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pete Leland, a 20-year veteran of the biotechnology industry, has joined Genovac Antibody Discovery, Fargo, N.D., as its vice president of production and characterization.
read more
GenScript Biotech Corporation along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated announced that they have entered into a strategic licensing agreement for Ligand's OmniAb® Platform, a multi-species antibody discovery...
read more
Monday, November 15, 2021
GenScript USA Inc., the world's leading life science research tools and services provider, announced today that it has opened a larger than 50,000-square-foot facility for highly automated gene synthesis and plasmid preparation services near its U.S....
read more
GenScript® has launched a single-stranded DNA (ssDNA) service.
read more
Monday, December 30, 2019
GenScript has announced it signed a strategic collaboration agreement with Selecxine, a Korean biotech company dedicated to novel therapeutics for immuno-oncology.
read more
Wednesday, March 29, 2017
Genstar Capital, a middle-market private equity firm focused on investments in targeted segments of the healthcare, financial services, software, and industrial technology industries, has acquired Bracket, a scientifically-driven clinical trial ...
read more
George Clinical announced the company acquired Vector Oncology's Pharma Services Division.
read more
Tuesday, December 19, 2017
George Clinical has announced Matthew Reabold, Sr. has been promoted to the Head of Business Development, USA.
read more
George Clinical announced it has rebranded to become Emerald Clinical Trials. This strategic name change underscores the company's well-established position as a dedicated, reliable, consistent, and flexible CRO, while mitigating global clinical ...
read more
Thursday, January 14, 2021
GeoVax Labs announced the NIAID, part of the NIH, has awarded the Company a SBIR grant in support of its development of a vaccine against SARS-CoV-2.
read more
Wednesday, January 29, 2020
GeoVax Labs and BravoVax announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV).
read more
Richter-Helm BioLogics GmbH & Co. KG has announced the start of construction for an expansion project at its cGMP manufacturing facility in Bovenau, Germany.
read more
The company created bioGO in response to limited and rigid infrastructure options for launching biopharmaceutical projects.
read more
Gerresheimer AG is planning to build a new plant in Skopje, Republic of North Macedonia.
read more
Gerresheimer announced investments to rapidly expand manufacturing, supply and logistics capacity for glass vials in the U.S. The project will be supported by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
read more